Gareth Jones is head of corporate affairs at the National Pharmacy Association
Community pharmacy’s flat funding settlement in England is linked to ‘efficiencies’ to be made through the hub-and-spoke model. With a consultation on the model on the cards for 2020, it is time to reconsider whether its benefits stack up.
The government’s decision to cut funding on a large scale for community pharmacy is short-sighted and will cause long-term damage to patients and pharmacy.
The Directive on counterfeit medicines will be complicated to implement and comply with, but it is in everyone’s interest to start thinking about the issues now and get it right first time.